{"id":240,"date":"2009-03-31T22:00:38","date_gmt":"2009-03-31T22:00:38","guid":{"rendered":"http:\/\/occamstypewriter.org\/trading-knowledge\/2009\/03\/31\/journal_surprises\/"},"modified":"2009-03-31T22:00:38","modified_gmt":"2009-03-31T22:00:38","slug":"journal_surprises","status":"publish","type":"post","link":"https:\/\/occamstypewriter.org\/trading-knowledge\/2009\/03\/31\/journal_surprises\/","title":{"rendered":"Journal surprises"},"content":{"rendered":"

I’ve written before<\/a> on the phenomenon of new journals. I’m particularly fascinated by the way that families of titles develop. In recent months we have seen Science Signaling<\/em><\/a> out of the AAAS stable, EMBO Molecular Medicine<\/em><\/a> from EMBO, and Nature Chemistry<\/em><\/a> from Nature Publishing Group (NPG). The latter title is just the latest in a long stream from NPG. In the last 15 years the growth of the Nature brand has been remarkable. I remember the first issue of the curiously titled Bio\/technology<\/em> in 1983, and the relief when the title changed in 1996 to Nature Biotechnology<\/em> with no punctuation marks. (I wonder if there have been any other journals with unusual punctuation in their titles?). By then Nature Genetics<\/em> and Nature Medicine<\/em> had appeared, so the family was well-established. But new Nature babies kept appearing, making us Librarians pray for the publishing equivalent of birth control. Just as we thought all subject areas had been covered then in 2000 NPG started the Nature Reviews<\/em> series with another seven titles, followed a few years later by the Nature Clinical Protocols<\/em> series, now in the process of being rebranded as Nature Reviews<\/em>. One of my colleagues recalls how happy she was when in 2002 NPG launched a new non-biomedical<\/strong> title (_Nature Materials_)- at last an NPG title that she didn’t have to subscribe to!
\nThe most remarkable thing about this family of Nature-branded journals – now 32 strong by my count – is that the publisher has maintained excellence across all these titles. The original brand is not diluted but rather enhanced by the extensions. Someone in Crinnan Towers clearly knows their business (and that’s Business with a capital $).
\nThe latest news from NPG to reach my ears is that they planning another launch, this time not in a specialised field but bang in the centre of science. It’s to be called Nature Science<\/em>, with a mission “to place before the general public the grand results of advancing science, serving society”. They will also make their first foray into social sciences with the launch of Nature Economics<\/em>, “to take part in a severe contest between intelligence and ignorance, giving early information of all advances made in any branch of Natural knowledge”. These two will be closely followed by Nature Royal<\/em>, probably a joint venture between NPG and the Royal Society but possibly a step downmarket in a NPG and Hello!<\/em><\/a> link-up. A bit later down the road we may see a move into the market for mother and baby magazines with NeoNature Nurture<\/em>.
\nFrom further afield I hear of counter launches from AAAS<\/a> – bringing out Science Nature<\/em> – and from Pearson<\/a> – bringing out The Economical Naturist<\/em>.
\nNPG are also continuing their strategy of innovations in emerging communications technology, with the launch of Nature Twitter<\/em>, specially designed to be compatible with the new Nature Phone – the N-Phone<\/em>. Meanwhile, a group of radical OA activists have announced their plans to send out each weekly issue of Nature<\/em> as a series of tweets, one sentence at a time. They call this Twitter Nature<\/em>, or Twitcher<\/em> for short.
\n.
\n.
\n.
\n.
\n.
\nAnd then I woke up, and took another paracetamol.<\/p>\n","protected":false},"excerpt":{"rendered":"

I’ve written before on the phenomenon of new journals. I’m particularly fascinated by the way that families of titles develop. In recent months we have seen Science Signaling out of the AAAS stable, EMBO Molecular Medicine from EMBO, and Nature … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":17,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-240","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/occamstypewriter.org\/trading-knowledge\/wp-json\/wp\/v2\/posts\/240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/occamstypewriter.org\/trading-knowledge\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/occamstypewriter.org\/trading-knowledge\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/occamstypewriter.org\/trading-knowledge\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/occamstypewriter.org\/trading-knowledge\/wp-json\/wp\/v2\/comments?post=240"}],"version-history":[{"count":0,"href":"https:\/\/occamstypewriter.org\/trading-knowledge\/wp-json\/wp\/v2\/posts\/240\/revisions"}],"wp:attachment":[{"href":"https:\/\/occamstypewriter.org\/trading-knowledge\/wp-json\/wp\/v2\/media?parent=240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/occamstypewriter.org\/trading-knowledge\/wp-json\/wp\/v2\/categories?post=240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/occamstypewriter.org\/trading-knowledge\/wp-json\/wp\/v2\/tags?post=240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}